These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27410520)

  • 1. Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer.
    Darshi M; Van Espen B; Sharma K
    Am J Nephrol; 2016; 44(2):92-103. PubMed ID: 27410520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease.
    Pereira PR; Carrageta DF; Oliveira PF; Rodrigues A; Alves MG; Monteiro MP
    Med Res Rev; 2022 Jul; 42(4):1518-1544. PubMed ID: 35274315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics for clinical use and research in chronic kidney disease.
    Hocher B; Adamski J
    Nat Rev Nephrol; 2017 May; 13(5):269-284. PubMed ID: 28262773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
    Lucio-Gutiérrez JR; Cordero-Pérez P; Ávila-Velázquez JL; Torres-González L; Farías-Navarro IC; Govea-Torres G; Sánchez-Martínez C; García-Hernández PA; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Waksman-Minsky NH; Saucedo AL
    J Pharm Biomed Anal; 2024 Sep; 247():116240. PubMed ID: 38820837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
    Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.
    Chen DQ; Chen H; Chen L; Vaziri ND; Wang M; Li XR; Zhao YY
    Nephrol Dial Transplant; 2017 Jul; 32(7):1154-1166. PubMed ID: 28339984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Zhang J; Fuhrer T; Ye H; Kwan B; Montemayor D; Tumova J; Darshi M; Afshinnia F; Scialla JJ; Anderson A; Porter AC; Taliercio JJ; Rincon-Choles H; Rao P; Xie D; Feldman H; Sauer U; Sharma K; Natarajan L
    Am J Nephrol; 2022; 53(2-3):215-225. PubMed ID: 35196658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.
    Sharma K; Karl B; Mathew AV; Gangoiti JA; Wassel CL; Saito R; Pu M; Sharma S; You YH; Wang L; Diamond-Stanic M; Lindenmeyer MT; Forsblom C; Wu W; Ix JH; Ideker T; Kopp JB; Nigam SK; Cohen CD; Groop PH; Barshop BA; Natarajan L; Nyhan WL; Naviaux RK
    J Am Soc Nephrol; 2013 Nov; 24(11):1901-12. PubMed ID: 23949796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics in chronic kidney disease.
    Zhao YY
    Clin Chim Acta; 2013 Jun; 422():59-69. PubMed ID: 23570820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic biomarkers in diabetic kidney diseases--A systematic review.
    Zhang Y; Zhang S; Wang G
    J Diabetes Complications; 2015; 29(8):1345-51. PubMed ID: 26253264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.
    Chen H; Cao G; Chen DQ; Wang M; Vaziri ND; Zhang ZH; Mao JR; Bai X; Zhao YY
    Redox Biol; 2016 Dec; 10():168-178. PubMed ID: 27750081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients.
    Li L; Wang C; Yang H; Liu S; Lu Y; Fu P; Liu J
    Mol Biosyst; 2017 Oct; 13(11):2392-2400. PubMed ID: 28956034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease.
    Huang G; Li M; Li Y; Mao Y
    Lab Med; 2022 Nov; 53(6):545-551. PubMed ID: 35748329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics.
    Harrison LE; Giardina C; Hightower LE; Anderson C; Perdrizet GA
    Cell Stress Chaperones; 2018 Nov; 23(6):1143-1152. PubMed ID: 30374882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of renal metabolomics.
    Kalim S; Rhee EP
    Kidney Int; 2017 Jan; 91(1):61-69. PubMed ID: 27692817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease: Biomarker diagnosis to therapeutic targets.
    Wang YN; Ma SX; Chen YY; Chen L; Liu BL; Liu QQ; Zhao YY
    Clin Chim Acta; 2019 Dec; 499():54-63. PubMed ID: 31476302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
    Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
    Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease.
    Hasegawa S; Inagi R
    Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic biomarkers for chronic kidney disease.
    Breit M; Weinberger KM
    Arch Biochem Biophys; 2016 Jan; 589():62-80. PubMed ID: 26235490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.